Such dysregulation has not been demonstrated in the model of PD utilized in this study; thus, mTORC1, or S6K inhibition, is likely to correct memory deficits independently of a preexisting condition of mTORC1 hyperactivation. This evidence concerns the gene RPS6KB1 and Parkinson disease.